Systemic Mastocytosis: Clinical Trials

1 trial for Systemic Mastocytosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow Systemic Mastocytosis: new trials by email Literature Review of Systemic Mastocytosis trials Research Report on Systemic Mastocytosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis
Cladribine and pegylated interpheron alpha-2a - Systemic Mastocytosis
Phase 2 / Phase 3UnknownHospital Virgen de la Salud102012-05-012016-08-29

Narrower conditions

Mast Cell Activation Disorders (1)  ·  Mastocytosis (1)  ·  Mastocytosis, Systemic (1)

Broader conditions

Immune System Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)

Interventions

Cladribine (1)

Sponsors

Hospital Virgen de la Salud (1)

Countries

Spain (1)

Top investigators

Luis Escribano, MD, PhD (1)